Unither Pharmaceuticals Unither Pharmaceuticals is a company that engages in sterile unit-doses contract manufacturing. | ![]() Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations. | ![]() Cell Signaling Technology Cell Signaling Technology is a company that develops and produces research products. | |||
Founding Date | Founding Date 1961 | Founding Date N/A | Founding Date 1993 | Founding Date 1977 | Founding Date 1999 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Mumbai, IN HQ | Locations Chippenham, GB HQ Saint Quentin Fallavier, FR Gauting, DE München, DE Muttenz, CH London, GB London, GB see more | Locations Mumbai, IN HQ Mumbai, IN | Locations Danvers, US HQ Chiyoda City, JP Leiden, NL Leiden, NL Beverly, US Boston, US | |
Employees | Employees 5,4971% increase | Employees 502 | Employees 1,4801% increase | Employees 14,989 | Employees 1,8141% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹131.5b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹46.7b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit £2.3m (FY, 2022) | Gross profit N/A | Gross profit ₹87b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income (£158m) (FY, 2022) | Net income N/A | Net income ₹10.5b (FY, 2025) | Net income N/A |

Vectura Group is a product development company that focuses on drug delivery.
View companyUnither Pharmaceuticals is a company that engages in sterile unit-doses contract manufacturing.
View company
Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
View company
Cell Signaling Technology is a company that develops and produces research products.
View company